Aquestive Therapeutics, Inc (AQST) insider trading
Every open-market stock purchase and sale by Aquestive Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Daniel Barber (CEO) and 1 other sold $379K in the last 90 days.
- Last insider buy: Peter E. Boyd (VP), $4K, 4 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $2.4M (15 sales). Last close $4.08 on Oct 21, 2026.
Recent AQST insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 15, 2026 | Daniel Barber (CEO) | Sold | $106K |
| Sep 15, 2026 | Daniel Barber (CEO) | Sold | $120K |
| Sep 9, 2026 | Sherry Korczynski (C-suite exec) | Sold | $45.7K |
| Sep 9, 2026 | Sherry Korczynski (C-suite exec) | Bought (not open market) | $23.2K |
| Sep 9, 2026 | Peter E. Boyd (C-suite exec) | Bought (not open market) | $2.2K |
| Sep 9, 2026 | Peter E. Boyd (C-suite exec) | Bought (not open market) | — |
| Sep 9, 2026 | Sherry Korczynski (C-suite exec) | Bought (not open market) | — |
| Sep 8, 2026 | Daniel Barber (CEO) | Bought (not open market) | $88.1K |
| Sep 8, 2026 | Daniel Barber (CEO) | Bought (not open market) | — |
| Sep 3, 2026 | Cassie Jung (COO) | Bought (not open market) | $4.4K |
| Sep 3, 2026 | Cassie Jung (COO) | Bought (not open market) | — |
| Aug 17, 2026 | Daniel Barber (CEO) | Sold | $107K |
| Aug 14, 2026 | Sherry Korczynski (C-suite exec) | Sold (not open market) | $11.5K |
| Jul 16, 2026 | Daniel Barber (CEO) | Sold | $81.5K |
| Jul 15, 2026 | Daniel Barber (CEO) | Sold | $18.7K |
| Jun 23, 2026 | Julie Krop (Insider) | Sold | $125K |
| Jun 23, 2026 | Julie Krop (Insider) | Bought (not open market) | — |
| Jun 15, 2026 | Daniel Barber (CEO) | Sold | $104K |
| Jun 10, 2026 | Gregory B Brown (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Marco Taglietti (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | John Cochran (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Abigail L. Jenkins (Insider) | Sold (not open market) | — |
| Jun 10, 2026 | Julie Krop (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Timothy E Morris (Insider) | Bought (not open market) | — |
| Jun 8, 2026 | Sherry Korczynski (C-suite exec) | Sold (not open market) | — |
Who's trading AQST
- Daniel Barber, CEO: sold $1.3M (8 sales), last Oct 15, 2026
- Peter E. Boyd, C-suite exec: sold $124K (1 sale), last Sep 9, 2026
- Sherry Korczynski, C-suite exec: sold $111K (2 sales), last Sep 9, 2026
- Cassie Jung, COO: sold $191K (1 sale), last Sep 3, 2026
- Julie Krop, Insider: sold $125K (1 sale), last Jun 23, 2026
- Timothy E Morris, Insider: other filings, last Jun 10, 2026
- Marco Taglietti, Insider: other filings, last Jun 10, 2026
- Gregory B Brown, Insider: other filings, last Jun 10, 2026
- Abigail L. Jenkins, Insider: other filings, last Jun 10, 2026
- John Cochran, Insider: other filings, last Jun 10, 2026
- Thomas A. Zalewski, C-suite exec: other filings, last May 18, 2026
- Melina Cioffi, VP: sold $106K (1 sale), last May 15, 2026
- Lori J Braender, C-suite exec: sold $167K (1 sale), last May 7, 2026
- A Ernest Toth Jr, CFO: sold $243K (1 sale), last May 5, 2026
- Matthew J. Greenhawt, C-suite exec: other filings, last Mar 9, 2026
Get free alerts when an insider at Aquestive Therapeutics, Inc files a new trade →